Opinion: STAT+: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs
The necessary roughness of 2023 has set up a very promising 2024 for the biotech job market.
What a week — this year’s might have been the busiest JPM I’ve ever had. I’m not saying that to brag, it’s a statement about the industry. There was even one tweet from STAT’s Adam Feuerstein calling the meeting mood “jubilant.” As a partner at an executive search firm, I’d concur. My time was packed with the usual mix of requests from potential, current, and former clients as well as investors to discuss search projects, and of course the meeting requests from potential candidates.
Perhaps most notably: I didn’t encounter nearly as many “can you please help me find a job?” requests as last year. That suggests to me that 2024 will be a better year for the industry’s job seekers.
The year 2023 was rough for everyone in this sector, including recruiters. There was still plenty for us to do, and we’ve had some really great placements, but it was slower than the prior year.
What's Your Reaction?
